Not applicableEnded earlyNCT02306135What this trial is testingIdentifying Mechanisms of Resistance to mTOR Inhibitors in CancerWho this might be right forCancer Dartmouth-Hitchcock Medical Center 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06708455What this trial is testingPhase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 MelanomaWho this might be right forMalignant Melanoma With MetastasisMalignant MelanomaMalignant Melanoma Stage IIIc+1 more Rapa Therapeutics LLC 65
Early research (Phase 1)Study completedNCT00770263What this trial is testingErlotinib and Temsirolimus for Solid TumorsWho this might be right forSolid Tumors Washington University School of Medicine 46
Testing effectiveness (Phase 2)Study completedNCT05835999What this trial is testingEverolimus Aging StudyWho this might be right forAgingInsulin Resistance University of Wisconsin, Madison 106
Testing effectiveness (Phase 2)Study completedNCT02407054What this trial is testingEnzalutamide and LY3023414 in Men With Prostate CancerWho this might be right forProstate Cancer Metastatic Eli Lilly and Company 142
Large-scale testing (Phase 3)Looking for participantsNCT05534672What this trial is testingPlacebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis ComplexWho this might be right forTuberous Sclerosis Complex Katarzyna Kotulska 200
Not applicableWithdrawnNCT07329088What this trial is testingIsoleucine Addition Treatment Effects in a Controlled Diet StudyWho this might be right forPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Metabolic Syndrome (MetS)Obesity & Overweight Jean L. Fry
Testing effectiveness (Phase 2)Study completedNCT02091531What this trial is testingDual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) PatientsWho this might be right forMetastatic Castration-Resistant Prostate Cancer Memorial Sloan Kettering Cancer Center 9
Testing effectiveness (Phase 2)Ended earlyNCT01020305What this trial is testingTemsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate CancerWho this might be right forProstate CancerProstatic NeoplasmsCastrate-resistant Prostate Cancer (CRPC)+3 more Sandy Srinivas 5
Early research (Phase 1)Study completedNCT01353625What this trial is testingStudy to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.Who this might be right forGlioblastoma MultiformeSquamous Cell Carcinoma of Head and NeckProstate Cancer+3 more Celgene 118
Testing effectiveness (Phase 2)Study completedNCT00827684What this trial is testingTemsirolimus and Irinotecan for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS MutationsWho this might be right forMetastatic Colorectal Cancer Vejle Hospital 50
Early research (Phase 1)Ended earlyNCT01174199What this trial is testingTemsirolimus and Vorinostat in Treating Patients With Metastatic Prostate CancerWho this might be right forProstate CancerAdenocarcinoma of the ProstateHormone-resistant Prostate Cancer+2 more Roswell Park Cancer Institute 13
Testing effectiveness (Phase 2)UnknownNCT00319878What this trial is testingSirolimus and Cyclosporine for Treatment-Resistant Aplastic AnemiaWho this might be right forAnemia, Aplastic Office of Rare Diseases (ORD) 52
Testing effectiveness (Phase 2)Ended earlyNCT00887640What this trial is testingImpact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate CancerWho this might be right forProstate Cancer Duke University 11